Subscribe to Newsletter

Search

Reset Filter
You have a filtered search result

268 search results for ‘*’

Discovery & Development Drug Discovery

Top Treatment Prospects: Alzheimer’s Disease

| Jamie Irvine | 9 min read

Experts discuss the most exciting Alzheimer’s Disease treatment trends – and make bold predictions for the future

Manufacture Advanced Medicine

Advanced Therapies, Archaic Hardware: the Perils of Paper

| Matt Todd | 4 min read

Here’s how paper is weighing down the future of advanced therapies.

Discovery & Development Drug Discovery

Advancements in the Fight Against Alzheimer's Disease

| Mallikarjun Chityala | 3 min read

Progress in Alzheimer’s Disease research, but a cure will take time. Delaying it and disseminating that research may buy scientists the time they need

Discovery & Development Drug Discovery

Treating the Fentanyl Epidemic

| Andrew Barrett | 4 min read

How – and why – we are tackling opioid use disorder with a monoclonal antibody

Manufacture Bioprocessing - Upstream & Downstream

Pushing the Boundaries of Bioprocessing

| Jungmin Oh | 4 min read

Biopharma tech continues to advance so why is downstream processing such a headache?

Business & Regulation Standards & Regulation

Saying Farewell to the Famous Horse Tweet

| Stephanie Vine | 5 min read

Why the FDA must delete its statement that people are not horses (or cows), referring to ivermectin use

Manufacture Bioprocessing - Upstream & Downstream

Five Thoughts: Cell Culture Media

| Sinan Ozer | 2 min read

Looking at key milestones, challenges, and innovations in cell culture media – and what lies in store ahead.

Discovery & Development Dosage Forms

Beyond ‘Bikini Medicine’

| Miriam Kenrick, Sarah Sowerby | 5 min read

Diseases can affect men and women differently. We must acknowledge and accept that – and then optimize drug development accordingly

Discovery & Development Clinical Trials

Charting the Future of IBD Trials

| Deepika Khedekar | 5 min read

Acknowledging the shortcomings in IBD-related clinical trials and a potential holistic approach to overcoming them

Manufacture Facilities

The Untouchables

| Rob Boulanger, Zach Page-Belknap | 3 min read

The benefits of closed processing are well-documented, but what about the sustainability angle?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register